Metabolomic profiling of oesophago-gastric cancer: A systematic review

European Journal of Cancer

Volumn 49, Issue 17, 2013, Pages 3625-3637

  Abbassi Ghadi, N ^a   Kumar, S ^a   Huang, J ^a   Goldin, R ^a   Takats, Z ^a   Hanna, G B ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Amino acids; Gastric cancer; Glycolysis; Lipids; Mass spectrometry; Metabolic profiling; Metabolomics; Nuclear magnetic resonance imaging; Oesophageal cancer; TCA cycle

Indexed keywords

ALDEHYDE DERIVATIVE; BIOLOGICAL MARKER; FUMARIC ACID; GLUTAMIC ACID; GLUTAMINE; KETONE DERIVATIVE; LACTIC ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID; VALINE;

ANAEROBIC CAPACITY; ARTICLE; CANCER PATIENT; CANCER SCREENING; CELL RESPIRATION; CITRIC ACID CYCLE; ESOPHAGUS CANCER; GLYCOLYSIS; HUMAN; LIPID METABOLISM; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN METABOLISM; STOMACH CANCER;

AMINO ACIDS; GASTRIC CANCER; GLYCOLYSIS; LIPIDS; MASS SPECTROMETRY; METABOLIC PROFILING; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE IMAGING; OESOPHAGEAL CANCER; TCA CYCLE;

ADENOCARCINOMA; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; HUMANS; METABOLOME; METABOLOMICS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84886782667     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.07.004     Document Type: Article

References (68)

1. A. Jemal, F. Bray, and M.M. Center Global cancer statistics CA Cancer J Clin 61 2 2011 69 90
2. M.B. Cook, W.H. Chow, and S.S. Devesa Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005 Br J Cancer 101 2009 855 859
3. C. Lepage, B. Rachet, V. Jooste, J. Faivre, and M.P. Coleman Continuing rapid increase in esophageal adenocarcinoma in England and Wales Am J Gastroenterol 103 2008 2694 2699
4. C. Bosetti, F. Levi, and J. Ferlay Trends in oesophageal cancer incidence and mortality in Europe Int J Cancer 122 2008 1118 1129
5. A. Jemal, R. Siegel, and E. Ward Cancer statistics 2009 CA Cancer J Clin 59 2009 225 249
6. The NHS Information Centre. National oesophago-gastric cancer audit 2010. [online] < http://www.ic.nhs.uk/webfiles/Services/NCASP/ audits%20and%20reports/NHS%20IC%20OGC%20Audit%202010%20interactive.pdf >; 2010 [accessed 1 November 2012].
7. C. Mariette, G. Taillier, I. Van Seuningen, and J.P. Triboulet Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma Ann Thorac Surg 78 4 2004 1177 1183
8. G.B. Hanna, P.R. Boshier, A. Knaggs, R. Goldin, and M. Sasako Improving outcomes after gastroesophageal cancer resection: can Japanese results be reproduced in Western centres? Arch Surg 147 8 2012 738 745
9. Y. Isobe, A. Nashimoto, and K. Akazawa Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry Gastric Cancer 14 4 2011 301 316
10. E. Holmes, I.D. Wilson, and J.K. Nicholson Metabolic phenotyping in health and disease Cell 134 5 2008 714 717
11. D.S. Wishart, T. Jewison, and A.C. Guo HMDB 3.0 - the human metabolome database in 2013 Nucleic Acids Res 41 2013 [database issue]
12. J.K. Nicholson, J. Connelly, J.C. Lindon, and E. Holmes Metabonomics: a platform for studying drug toxicity and gene function Nat Rev Drug Disc 1 2002 153 161
13. S. Nishiumi, T. Kobayashi, and A. Ikeda A novel serum metabolomics-based diagnostic approach for colorectal cancer PLoS One 7 7 2012 [epub ahead of print]
14. M. Phillips, K. Gleeson, and J.M. Hughes Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study Lancet 353 9168 1999 1930 1933
15. A. Sreekumar, L.M. Poisson, and T.M. Rajendiran Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 12 2009 910 914
16. P.F. Whiting, A.W. Rutjes, and M.E. Westwood QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Ann Intern Med 155 8 2011 529 536
17. P. Whiting, A.W. Rutjes, and J.B. Reitsma Sources of variation and bias in studies of diagnostic accuracy: a systematic review Ann Intern Med 140 2004 189 202
18. C.W. Mun, J.Y. Cho, and W.J. Shin Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma Magn Reson Imaging 22 6 2004 861 870
19. V. Tugnoli, A. Mucci, and L. Schenetti Ex vivo HR-MAS magnetic resonance spectroscopy of human gastric adenocarcinomas: a comparison with healthy gastric mucosa Oncol Rep 16 3 2006 543 553
20. T. Ligor, J. Szeliga, M. Jackowski, and B. Buszewski Preliminary study of volatile organic compounds from breath and stomach tissue by means of solid phase microextraction and gas chromatography-mass spectrometry J Breath Res 1 1 2007 1 6
21. B. Buszewski, A. Ulanowska, and T. Ligor Identification of volatile organic compounds secreted from cancer tissues and bacterial cultures J Chromatogr B Analyt Technol Biomed Life Sci 868 1-2 2008 88 94
22. A. Hirayama, K. Kami, and M. Sugimoto Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry Cancer Res 69 11 2009 4918 4925
23. Z. Cai, J.S. Zhao, and J.J. Li A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism Mol Cell Proteomics 9 12 2010 2617 2628
24. H. Wu, R. Xue, and Z. Tang Metabolomic investigation of gastric cancer tissue using gas chromatography mass spectrometry Anal Bioanal Chem 396 2010 1385 1395
25. H. Song, L. Wang, and H.L. Liu Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity Oncol Rep 6 2011 431 438
26. C. Calabrese, A. Pisi, and G. Di Febo Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy Cancer Epidemiol Biomarkers Prev 17 6 2008 1386 1395
27. L. Yu, J. Aa, and J. Xu Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry J Gastroenterol Hepatol 26 8 2011 1290 1297
28. A. Ikeda, S. Nishiumi, and M. Shinohara Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer Biomed Chromatogr 26 5 2012 548 558
29. H. Song, J.S. Peng, and D.S. Yao Serum metabolic profiling of human gastric cancer based on gas chromatography mass spectrometry Braz J Med Biol Res 45 1 2012 78 85
30. J. Aa, L. Yu, and M. Sun Metabolic features of the tumor microenvironment of gastric Metabolomics 8 2012 164 173
31. H. Wu, R. Xue, and C. Lu Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 877 27 2009 3111 3117
32. D. Yakoub, H.C. Keun, R. Goldin, and G.B. Hanna Metabolic profiling detects field effects in nondysplastic tissue from esophageal cancer patients Cancer Res 70 22 2010 9129 9136
33. D. Djukovic, H.R. Baniasadi, R. Kc, Z. Hammoud, and D. Raftery Targeted serum metabolite profiling of nucleosides in esophageal adenocarcinoma Rapid Commun Mass Spectrom 24 20 2010 3057 3062
34. J. Zhang, L. Liu, and S. Wei Metabolomics study of esophageal adenocarcinoma J Thorac Cardiovasc Surg 141 2 2011 469 475
35. J. Zhang, J. Bowers, and L. Liu Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods PLoS One 7 1 2012 1 10
36. S. Kumar, J. Huang, and J.R. Cushnir Selected ion flow tube-MS analysis of headspace vapor from gastric content for the diagnosis of gastro-esophageal cancer Anal Chem 84 21 2012 9550 9557
37. 1H-NMR spectroscopy and its association with the clinicopathological characteristics Mol Biol Rep 39 9 2012 8955 8964
38. L. Laffel Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes Diabetes Metab Res Rev 15 6 1999 412 426
39. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
40. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
41. G. Kroemer, and J. Pouyssegur Tumor cell metabolism: cancer's Achilles' heel Cancer Cell 13 2008 472 482
42. S. Romero-Garcia, J.S. Lopez-Gonzalez, J.L. Báez-Viveros, D. Aguilar-Cazares, and H. Prado-Garcia Tumor cell metabolism: an integral view Cancer Biol Ther 12 11 2011 939 948
43. O. Warburg, F. Wind, and E. Negelein The metabolism of tumours in the body J Gen Physiol 8 6 1927 519 530
44. O. Warburg On the origin of cancer cells Science 123 1956 309 314
45. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 5930 2009 1029 1033
46. R.A. Gatenby, and R.J. Gillies Why do cancers have high aerobic glycolysis Nat Rev Cancer 4 2004 891 899
47. A. Schulze, and A.L. Harris How cancer metabolism is tuned for proliferation and vulnerable to disruption Nature 491 7424 2012 364 373
48. J.M. Matés, J.A. Segura, and J.A. Campos-Sandoval Glutamine homeostasis and mitochondrial dynamics Int J Biochem Cell Biol 41 2009 2051 2061
49. R.J. DeBerardinis Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis Proc Natl Acad Sci U S A 104 2007 19345 19350
50. J.M. Argilés, and J. Azcón-Bieto The metabolic environment of cancer Mol Cell Biochem 81 1988 3 17
51. C.R. Santos, and A. Schulze Lipid metabolism in cancer FEBS J 279 2012 2610 2623
52. M.T. Accioly, P. Pacheco, and C.M. Maya-Monteiro Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells Cancer Res 68 2008 1732 1740
53. J.A. Menendez, and R. Lupu Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat Rev Cancer 7 2007 763 777
54. R.J. Deberardinis, N. Sayed, D. Ditsworth, and C.B. Thompson Brick by brick: metabolism and tumor cell growth Curr Opin Genet Dev 18 2008 54 61
55. T. Mashima, H. Seimiya, and T. Tsuruo De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy Br J Cancer 100 2009 1369 1372
56. Y. Liu Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer Prostate Cancer Prostatic Dis 9 2006 230 234
57. J. Khasawneh, M.D. Schulz, and A. Walch Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion Proc Natl Acad Sci U S A 106 2009 3354 3359
58. K. Bartlett, and S. Eaton Mitochondrial β-oxidation Eur J Biochem 271 2004 462 469
59. S. Ganti, S.L. Taylor, and K. Kim Urinary acylcarnitines are altered in human kidney cancer Int J Cancer 130 12 2012 2791 2800
60. J. Chen, W.Z. Wang, and S. Lv Metabonomics study of liver cancer based on ultra-performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations Anal Chim Acta 650 2009 3 9
61. Y.P. Qiu, G.X. Cai, and M.M. Su Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS J Proteome Res 8 2009 4844 4850
62. J. Xu, Y. Chen, and R. Zhang Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers Mol Cell Proteomics 2013 [epub ahead of print]
63. D. Wang, and R.N. Dubois Eicosanoids and cancer Nat Rev Cancer 10 3 2010 181 193
64. S. Shimakura, and C.R. Roland Eicosanoid production by the human gastric cancer cell line ACS and its relation to cell growth Cancer Res 52 1992 1744 1749
65. X. Chen, N. Li, and S. Wang Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model Carcinogenesis 23 12 2002 2095 2102
66. A. Bennett, A. Civier, C.N. Hensby, P.B. Melhuish, and I.F. Stamford Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues Gut 28 3 1987 315 318
67. L.M. Dong, X.O. Shu, and Y.T. Gao Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study Cancer Epidemiol Biomarkers Prev 18 11 2009 3075 3078
68. F. Guéraud, M. Atalay, and N. Bresgen Chemistry and biochemistry of lipid peroxidation products Free Radic Res 44 10 2010 1098 1124